Affiliation:
1. Key Laboratory of Molecular Pharmacology and Drug Evaluation, School of Pharmacy, Yantai University, Yantai 264005, China
2. Physiology Group, Department of Basic and Applied Medical Sciences, Ghent University, 9000 Ghent, Belgium
3. School of Pharmacy, Binzhou Medical University, Yantai 264003, China
Abstract
Dioscorea spp. belongs to the Dioscoreaceae family, known as “yams”, and contains approximately 600 species with a wide distribution. It is a major food source for millions of people in tropical and subtropical regions. Dioscorea has great medicinal and therapeutic capabilities and is a potential source of bioactive substances for the prevention and treatment of many diseases. In recent years, increasing attention has been paid to the phytochemicals of Dioscorea, such as steroidal saponins, polyphenols, allantoin, and, in particular, polysaccharides and diosgenin. These bioactive compounds possess anti-inflammatory activity and are protective against a variety of inflammatory diseases, such as enteritis, arthritis, dermatitis, acute pancreatitis, and neuroinflammation. In addition, they play an important role in the prevention and treatment of metabolic diseases, including obesity, dyslipidemia, diabetes, and non-alcoholic fatty liver disease. Their mechanisms of action are related to the modulation of a number of key signaling pathways and molecular targets. This review mainly summarizes recent studies on the bioactive compounds of Dioscorea and its treatment of inflammatory and metabolic diseases, and highlights the underlying molecular mechanisms. In conclusion, Dioscorea is a promising source of bioactive components and has the potential to develop novel natural bioactive compounds for the prevention and treatment of inflammatory and metabolic diseases.
Funder
National Natural Science Foundation of China
Subject
Chemistry (miscellaneous),Analytical Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Molecular Medicine,Drug Discovery,Pharmaceutical Science
Reference119 articles.
1. The Global Epidemic of the Metabolic Syndrome;Saklayen;Curr. Hypertens. Rep.,2018
2. Phytochemicals: Targeting Mitophagy to Treat Metabolic Disorders;Su;Front. Cell Dev. Biol.,2021
3. NF-κB, Inflammation, and Metabolic Disease;Baker;Cell Metab.,2011
4. Gasmi, A., Mujawdiya, P.K., Noor, S., Lysiuk, R., Darmohray, R., Piscopo, S., Lenchyk, L., Antonyak, H., Dehtiarova, K., and Shanaida, M. (2022). Polyphenols in Metabolic Diseases. Molecules, 27.
5. Therapeutic Effect of Berberine on Metabolic Diseases: Both Pharmacological Data and Clinical Evidence;Xu;Biomed. Pharmacother.,2021
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献